Palo Alto, Calif.-based Stanford Health Care’s credit rating was upgraded to “Aa2” from “Aa3” by Moody’s.
The upgrade reflects Stanford Health Care’s consistently strong financial performance, which will allow the system to finance growth strategies while maintaining good liquidity and manageable leverage, Moody’s said in a May 16 report.
Moody’s said the “Aa2” rating reflects the health system’s “brand and strategic positioning, which is distinguished by its clinical excellence and strong patient demand.”
“Its presence in a wealthy and well-insured market, along with its status as a wholly owned subsidiary of Stanford University, further enhances its financial stability,” Moody’s said.
Stanford Health Care has a stable outlook at its new rating, which reflects a continuation of high single-digit operating cash flow margins and maintenance of cash on hand above 250 days.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
